The changing role of natural killer cells in cancer metastasis

Area of Science:

• Immunology
• Cancer Biology
• Metastasis Research

Background:

• Natural killer (NK) cells are vital innate immune cells for antitumor and antimetastatic defense.
• Emerging immunotherapies aim to leverage NK cells for treating metastatic diseases.
• Understanding cancer cell-NK cell interactions during metastasis is crucial for therapeutic development.

Purpose of the Study:

• To review recent findings on the interactions between metastatic cancer cells and NK cells.
• To explore how cancer cell biology at different metastatic stages affects NK cell function.
• To discuss the potential for translating this knowledge into novel cancer treatments.

Main Methods:

• Literature review of recent studies on NK cell-cancer cell interactions in metastasis.
• Analysis of how cancer cell adaptations influence NK cell immunosurveillance and function.
• Examination of mechanisms by which cancer cells evade NK cell detection or co-opt NK cells.

Main Results:

• Cancer cells evolve unique biological strategies at each metastatic stage to evade NK cell recognition.
• Metastatic cancer cells can actively reprogram NK cells to promote tumor growth and spread.
• NK cell interactions with cancer cells are complex and context-dependent throughout the metastatic cascade.

Conclusions:

• NK cell-mediated immunosurveillance is significantly challenged by the evolving biology of metastatic cancer cells.
• Targeting cancer cell-mediated modulation of NK cells offers promising avenues for next-generation immunotherapies.
• Further research into these interactions is essential for advancing the clinical application of NK cell-based cancer therapies.